Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

May 16 2001
WASHINGTON, D.C. (May 16, 2001) -- It is likely that PresidentBush and Vice President Cheney will include bioenergy development in their new energy policy....
May 15 2001
WASHINGTON, D.C. (May 15, 2001) – Robert Chess, chairman of Inhale Therapeutic Systems, based in San Carlos, Calif., is scheduled to testify on behalf of the...
May 15 2001
WASHINGTON, D.C. (May 15, 2001) – Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) today released the following statement in...
May 14 2001
WASHINGTON, D. C. (May 14, 2001) – More than 200 meetings with Capitol Hill legislators are scheduled for biotechnology industry representatives during the...
May 11 2001
WASHINGTON, D.C. (May 11, 2001) – The U.S. Senate passed a resolution (attached) declaring May 13 – 20 National Biotechnology Week, thereby recognizing...
May 10 2001
WASHINGTON, D.C. (May 10, 2001) – Biotechnology Industry Organization (BIO) President Carl B. Feldbaum today issued the following statement after congressional...
May 10 2001
WASHINGTON, D.C. (May 10, 2001) – Lila Feisee, director of government relations and intellectual property at the Biotechnology Industry Organization (BIO),...
May 9 2001
Statement by Dr. Michael J. Phillips, Executive Director for Food and Agriculture WASHINGTON, D.C. (May 9, 2001) – “The development of a faster-growing salmon...
May 8 2001
WASHINGTON, D.C. (May 8, 2001) – Biotechnology Industry Organization (BIO) President Carl B. Feldbaum said today that HCFA’s proposed “New Technology” rule for...


Biotechnology News

August 21, 2014

DUBLIN--(BUSINESS WIRE)--Research and Markets (...

August 21, 2014

HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News: (STO:MVIR-B) Financial summary for the second quarter -- Net turnover totalled SEK 564.0 million (SEK 40.7 m), of which...

August 21, 2014

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced it has formed collaborative partnerships with leading pharmaceutical companies to develop a...

August 20, 2014

LOS ANGELES--(BUSINESS WIRE)--Researchers at Children’s Hospital Los Angeles have shown that a select team of immune-system cells from patients with leukemia can be...